by HTLV | Oct 12, 2022 | Publications
Cancer Immunol Immunother. 2022 Oct 1. doi: 10.1007/s00262-022-03301-6. Online ahead of print. ABSTRACT Adult T cell leukemia/lymphoma (ATLL) is a CD4-positive peripheral T cell lymphoma caused by human T cell lymphotropic virus type 1 (HTLV-1). Although ATLL is quite...
by HTLV | Oct 12, 2022 | Publications
Front Immunol. 2022 Sep 13;13:921606. doi: 10.3389/fimmu.2022.921606. eCollection 2022. ABSTRACT Human T-cell leukemia virus type-1 (HTLV-1) establishes a long-term persistent infection in humans and causes malignant T-cell leukemia, adult T-cell leukemia (ATL)....
by HTLV | Oct 12, 2022 | Publications
Mol Biol (Mosk). 2022 Sep-Oct;56(5):710-731. doi: 10.31857/S0026898422050020. ABSTRACT Viruses are now recognized as bona fide etiologic factors of human cancer. Carcinogenic viruses include Epstein-Barr virus (EBV), high-risk human papillomaviruses (HPVs), hepatitis...
by HTLV | Oct 12, 2022 | Publications
Front Immunol. 2022 Sep 15;13:984274. doi: 10.3389/fimmu.2022.984274. eCollection 2022. ABSTRACT Human T lymphotropic virus 1 (HTLV-1) is a human retrovirus identified as the causative agent in adult T-cell leukemia/lymphoma (ATL) and chronic-progressive...
by HTLV | Oct 12, 2022 | Publications
Front Immunol. 2022 Sep 16;13:959962. doi: 10.3389/fimmu.2022.959962. eCollection 2022. ABSTRACT HTLV-1 is an oncovirus causing ATL and other inflammatory diseases such as HAM/TSP and HU in about 5% of infected individuals. It is also known that HTLV-1-infected cells...
by HTLV | Oct 12, 2022 | Publications
Sci Rep. 2022 Oct 6;12(1):16701. doi: 10.1038/s41598-022-21086-7. ABSTRACT Human T-lymphotropic viruses 1 and 2 (HTLV-1/2) have a worldwide distribution. HTLV-1 has been associated with several diseases, including an aggressive malignant disease known as adult T-cell...
